Elacridar,98%

(The order shall be subject to the English name)

Product No.：E33100 CAS.：143664-11-3 Molecular formula：C₃₄H₃₃N₃O₅ MDL：MFCD00912604 Brand：Acmec

N-(4-(2-(6,7-二甲氧基-3,4-二氢异喹啉-2(1H)-基)乙基)苯基)-5-甲氧基-9-氧代-9,10-二氢吖啶-4-甲酰胺

Guess you like

3-Chloro-4-nitropyridine, 97%

CAS No：13194-60-0

Jatrophane 2, Analysis control,HPLC≥97.5%

CAS No：210108-86-4

2-Benzoyl-4-bromoaniline, 97%

CAS No：39859-36-4

Valeric anhydride, 98%

CAS No：2082-59-9

2-Acetoxy-2'，4'-difluoroacetophenone, 97%

CAS No：122263-03-0

2-(1-Tetrazolyl)benzonitrile, 95%

CAS No：449758-25-2

4-Ethylphenylboronic acid pinacol ester, ≥98%

CAS No：1075719-87-7

But-3-yn-2-yl 4-methylbenzenesulfonate, 96%

CAS No：53487-52-8

Diisopropyldichlorosilane, 97%

CAS No：7751-38-4

3-Aminobenzophenone 97%, 97%

CAS No：2835-78-1

6-Chloropicolinamide, 98%

CAS No：70593-61-2

5-Sulfosalicylic acid dihydrate, 97%

CAS No：5965-83-3

4-Methyl-4-nitrovaleraldehyde, ≥90%(GC)

CAS No：57620-49-2

(R)-(-)-2-[Hydroxy(diphenyl)methyl]-1-methylpyrrolidine, 99%

CAS No：144119-12-0

1-Octylpiperazine, 95%

CAS No：54256-45-0

5-(4-Fluorophenyl)-3-pyridinecarbaldehyde, 95%

CAS No：381684-96-4

Ethyl 5-chloro[1,2,4]triazolo[4,3-a]pyriMidine-7-carboxylate, 95%

CAS No：99951-90-3

4-Amino-1-methyl-1H-pyrazole-5-carbonitrile, 95%

CAS No：1393101-11-5

(11aR)-10，11，12，13-Tetrahydro-5-hydroxy-3，7-di-2-naphthalenyl-5-oxide-diindeno[7，1-de:1'，7'-fg][1，3，2]dioxaphosphocin, -

CAS No：1297613-74-1

4-Heptylbenzoyl chloride 99%, 99%

CAS No：50606-96-7

Introduction
Security information

Name：

Elacridar

CAS No.：

143664-11-3

Molecular formula：

C₃₄H₃₃N₃O₅

Molecular weight：

563.64

Density：

1.264±0.06 g/cm3(Predicted)

MeltingPoint：

216-218°C

BoilingPoint：

701.6±60.0°C(Predicted)

Solubility：

DMSO:41 mg/mL (72.74 mM);Ethanol:<1 mg/mL;Water:<1 mg/mL

WaterSolubility：

<1 mg/mL

Preservation conditions：

-20°C,Dark,Dry

InChIKey：

OSFCMRGOZNQUSW-UHFFFAOYSA-N

InChI：

InChI=1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38)

Pubchem ID：

119373

Biological Activity:
Elacridar (GF120918; GW0918) is a P-glycoprotein inhibitor, and has been used both in vitro and in vivo as a tool inhibitor of P-glycoprotein (Pgp) to investigate the role of transporters in the disposition of various test molecules.
Target: P-glycoprotein
In vitro, GF120918A demonstrated high plasma protein binding across species, although a definitive protein binding evaluation was precluded by poor recovery, particularly in buffer and in mouse, rat, and dog plasma. GF120918A did not demonstrate potent inhibition of several human cytochrome P450 enzymes evaluated in vitro, with IC(50) values well above concentrations anticipated to be achieved in vivo. Together, these data confirm the utility of GF120918A as a tool P-glycoprotein inhibitor in preclinical species and offer additional guidance on preclinical dose regimens likely to produce P-glycoprotein-mediated effects.

Solvent & Solubility: 10 mM in DMSO

Grade of hazardous chemicals：

For detailed properties of compounds, click“143664-11-3”

technical information

History browsing record